Evaluation of an eyelid cleansing gel for dry eye management
Research type
Research Study
Full title
Evaluation of Eyelid Cleansing Gel for Meibomian Glands Dysfunction Management
IRAS ID
246160
Contact name
Ali Mearza
Contact email
Sponsor organisation
Laboratoires Horus Pharma
Duration of Study in the UK
0 years, 8 months, 12 days
Research summary
Dry eye is a complex condition for which numerous management products have been developed to deal with the many aetiologies resulting in the condition. Most products are in the form of eyedrops or eyegel addressing the destabilization of the tear film, while other address the inflammatory component of dry eye. Sodium hyaluronate (Hyaluronate Acid (HA)) are used extensively in patients complaining of dry eye.
Horus Pharma has a range of products for dry eye sufferers with meibomian glands anomalies to use for home treatment.
ILAST® HYDRACLEAN, 0.2% sodium hyaluronate, CE marked cleansing gel for eyelid hygiene manufactured by Horus Pharma is designed for cleaning eyelids, particularly the inflamed eyelid margin. By removing the deposits, secretions or crusts present on the eyelids and the roots of the eyelashes, the clean eyelids will lessen the dry eye symptoms. The rationale for the proposed study is to determine the clinical performance of ILAST® HYDRACLEAN by quantifying the improvement in dry eye symptoms and meibomian gland status after four weeks using the study product. The results of this study will be used to power future comparative studies. Thirty symptomatic dry eye participants will be enrolled. There will be two study visits over a month period. Participants will be using the ILAST® HYDRACLEAN eyelid cleansing gel every day in the morning upon waking and at night prior to sleep by applying it on closed eyelid skin.REC name
London - Riverside Research Ethics Committee
REC reference
18/LO/0810
Date of REC Opinion
27 Apr 2018
REC opinion
Favourable Opinion